ArticleCancer letters2019

Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen Enzalutamide sensitivity to better suppress the castration-resistant prostate cancer growth.

Meng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.